Apyx Medical Corp (NASDAQ:APYX) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Charlie Goodwin - President and CEO Tara Semb - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - Dougherty & Company Russell Cleveland - RENN Capital Group Jeffrey Bernstein - Cowen Prime Advisors Operator Good afternoon, ladies and gentlemen, and welcome to the second quarter of fiscal year 2019 earnings conference call for Apyx Medical Corporation. [Operato ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 0-12183 Energy Elevating Lives APYX MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 11-2644611 ...

Apyx Medical Corporation (NASDAQ:APYX) Q1 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Charlie Goodwin – President and Chief Executive Officer Tara Semb – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Hallum Capital Kyle Bauser – Dougherty and Company Kevin Farshchi – Piper Jaffray Russell Cleveland – RENN Capital Operator Good morning, ladies and gentlemen, and welcome to the First Quarter of Fiscal Year 2019 Earnings Conference Call for Apyx ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 0-12183 Energy Elevating Lives APYX MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 11-2644611 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 0-12183 APYX MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 11-2644611 (State or other jurisdictio ...